Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 13/20 | 0.69 |
| ▸ | SLC6A3 | Q01959 | 13/20 | 0.69 |
| ▸ | SLC6A2 | P23975 | 12/20 | 0.69 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.47 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.47 |
| ▸ | HTR3B | O95264 | 1/20 | 0.47 |
| ▸ | HTR3A | P46098 | 1/20 | 0.47 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.47 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.44 |
| ▸ | WEE1 | P30291 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21360403 | 1.00 | SLC6A4 (0.69) | SLC6A4SLC6A3SLC6A2ADRB1SIGMAR1 | |
| SCHEMBL20141290 | 1.00 | SLC6A4 (0.69) | SLC6A4SLC6A3SLC6A2ADRB1SIGMAR1 | |
| SCHEMBL10385636 | 0.87 | SLC6A4 (0.66) | SLC6A4SLC6A3SLC6A2ADRB1SIGMAR1 | |
| SCHEMBL24028174 | 0.85 | SLC6A2 (0.51) | SLC6A4SLC6A3SLC6A2ADRB1CYP2D6 | |
| SCHEMBL22542019 | 0.84 | SLC6A2 (0.50) | SLC6A4SLC6A3SLC6A2ADRB1CYP2D6 | |
| SCHEMBL22542021 | 0.84 | SLC6A2 (0.50) | SLC6A4SLC6A3SLC6A2ADRB1CYP2D6 | |
| SCHEMBL16163362 | 0.84 | SLC6A2 (0.50) | SLC6A4SLC6A3SLC6A2ADRB1CYP2D6 | |
| SCHEMBL7149297 | 0.83 | SLC6A2 (0.69) | SLC6A4SLC6A3SLC6A2ADRB1SIGMAR1 | |
| SCHEMBL27504254 | 0.83 | SLC6A4 (0.69) | SLC6A4SLC6A3SLC6A2ADRB1SIGMAR1 | |
| SCHEMBL25154293 | 0.83 | SLC6A4 (0.64) | SLC6A4SLC6A3SLC6A2ADRB1CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10844013-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | NAVITOR PHARMACEUTICALS, INC. (US) | 2020-11-24 | — | — | US | disclosed |
| US-20200207716-A1 | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF | NAVITOR PHARMACEUTICALS, INC. | 2020-07-02 | — | — | US | disclosed |
| US-10414727-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | NAVITOR PHARMACEUTICALS, INC. (US) | 2019-09-17 | — | — | US | disclosed |
| WO-2018089433-A1 | PHENYL mTORC INHIBITORS AND USES THEREOF | NAVITOR PHARMACEUTICALS, INC. (US) | 2018-05-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10844013-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | MTOR, RICTOR, RPTOR | SLC6A4 1595/4885SLC6A3 2743/4885SLC6A2 3251/4885 |
| US-10414727-B2 | Phenyl amino piperidine mTORC inhibitors and uses thereof | MTOR, RICTOR, RPTOR | SLC6A4 1595/4885SLC6A3 2743/4885SLC6A2 3251/4885 |
| US-20200207716-A1 | PHENYL AMINO PIPERIDINE mTORC INHIBITORS AND USES THEREOF | MTOR, RICTOR, RPTOR | SLC6A4 1595/4885SLC6A3 2743/4885SLC6A2 3251/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.